EN
HI
Bliss GVS Pharma Chart
Bliss GVS Pharma Share Key Metrics
Volume
10.42 L
Market Cap
2852.60 CR
LTQ@LTP
17@272.00
ATP
273.37
Var Margin
27.17 %
Circuit Range
215.75-323.55
Delivery %
54.91 %
Value
28.49 CR
ASM/GSM
No
Market Lot
1
Summary
Bliss GVS Pharma share price stands at ₹272 at 11 May, 2026 | 13:31. The stock Bliss GVS Pharma intraday movement has stayed between ₹266.10 and ₹276.90, while on a 52-week basis it has fluctuated from ₹109.03 to ₹281.00.
In terms of trading activity, Bliss GVS Pharma has recorded a volume of 1042077 shares. The Bliss GVS Pharma has a market cap of ₹105788972. The stock’s Average Traded Price (ATP) stands at ₹27337, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 17, 27200.
The Bliss GVS Pharma operates within a circuit range of ₹215.75-323.55 – ₹215.75-323.55, with a Value of ₹28.49 CR. The Delivery Percentage for the day is 54.91%. Additionally, Bliss GVS Pharma currently falls under the No framework, and trades with a market lot size of 1.
Bliss GVS Pharma Fundamentals
View MoreP/E Ratio
26.12
P/B Ratio
2.46
Div. Yield
0.19
Sector P/E
68.46
Sector P/B
3.55
Sec. Div. Yield
0.57
Bliss GVS Pharma Resistance and Support
Pivot 271.4
Resistance
First Resistance
273.7
Second Resistance
277.75
Third Resistance
280.05
Support
First Support
267.35
Second Support
265.05
Third Support
261
Bliss GVS Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-10 | Quarterly Results & Interim Dividend |
| 2025-11-06 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results & Others |
Bliss GVS Pharma News
Bliss GVS Pharma Limited
BLISS GVS PHARMA's board is scheduled to meet on May 12, 2026. The agenda includes considering the audited financial results for the fiscal year ended March 2026, along with a proposal for a final dividend.
May 05 2026 18:05:00
Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend If Any, For The Year Ended March 31, 2026.
Bliss GVS Pharma's Board of Directors is scheduled to meet on May 12, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and recommending a final dividend for FY26.
May 05 2026 18:05:00
About Bliss GVS Pharma
NSE : 19265
BSE : 506197
ISIN : INE416D01022
Bliss GVS Pharma Management
| Name | Position |
|---|---|
| Aditi Bhatt | Company Secretary & Compliance Officer |
| Nandkumar chodankar | Chairman |
Bliss GVS Pharma Similar Stocks
Orchid Pharma Ltd.
718.00
14.55 (2.07%)
Aarti Drugs Ltd.
385.70
-2.20 (0.57%)
Gujarat Themis Biosyn Ltd.
385.00
-13.50 (3.39%)
Gufic Biosciences Ltd.
300.60
-1.85 (0.61%)
Dishman Carbogen Amcis Ltd.
183.26
-3.99 (2.13%)
IOL Chemicals And Pharmaceuticals Ltd.
109.75
12.86 (13.27%)
Unichem Laboratories Ltd.
382.60
-3.20 (0.83%)
Hikal Ltd.
212.40
1.65 (0.78%)
Solara Active Pharma Sciences Ltd.
522.00
-3.35 (0.64%)
Morepen Laboratories Ltd.
46.17
0.53 (1.16%)
Bliss GVS Pharma FAQs
The Buying Price of Bliss GVS Pharma share is 272 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bliss GVS Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bliss GVS Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bliss GVS Pharma shares is 26.12. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bliss GVS Pharma shares is 2.46. Useful to assess the stock's value relative to its book value.
To assess Bliss GVS Pharma’s valuation compare Sector P/E, P/B which are 68.46 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bliss GVS Pharma is 2852.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bliss GVS Pharma share price is 281.00 & 109.03. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bliss GVS Pharma belongs to the Healthcare sector.
